Author:
Ghosh Prosenjit,Gogoi Anshuman,Baidya Suman
Publisher
Jaypee Brothers Medical Publishing
Reference16 articles.
1. 1. NACP-IV components. n.d. Retrieved from: NACP-IV components|National AIDS Control Organization|MoHFW|GoI (naco.gov.in) [March 15, 2021].
2. 2. Substitution therapy with buprenorphine for opioid injecting drug users practice guidelines. n.d. Retrieved from: Bupenorphine_Practice_Guidelines.pdf (naco.gov.in) [March 15, 2021].
3. 3. Ball JC, Ross A. The effectiveness of methadone maintenance treatment: patients, programs, services, and outcome. Springer Science and Business Media; 2012.
4. 4. Bell J, Byron G, Gibson A, et al. A pilot study of buprenorphine-naloxone combination tablet (Suboxone®) in treatment of opioid dependence. Drug Alcohol Rev 2004;23(3):311–317. DOI: 10.1080/09595230412331289473.
5. 5. Finch JW, Kamien JB, Amass L. Two-year experience with buprenorphine-naloxone (Suboxone) for maintenance treatment of opioid dependence within a private practice setting. J Addict Med 2007;1(2):104–110. DOI: 10.1097/ADM.0b013e31809b5df2.